MAI Capital Management 13D and 13G filings for Trevi Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-07-10 4:16 pm Sale |
2022-05-12 | 13G | Trevi Therapeutics, Inc. TRVI |
MAI Capital Management | 1,519,650 2.200% |
-21,821 (-1.42%) |
Filing |
| 2022-04-08 10:41 am Purchase |
2022-03-30 | 13G | Trevi Therapeutics, Inc. TRVI |
MAI Capital Management | 1,541,471 5.000% |
1,541,471 (New Position) |
Filing |